Get SEC filing alerts via email and in your feed for Absci Corp
ABSI
Absci Corp
About Absci Corp
Absci Corporation is a biopharmaceutical company specializing in AI-driven antibody drug creation. Its Integrated Drug Creation platform combines generative AI, synthetic biology, and high-throughput wet-lab validation to design and optimize novel antibody therapeutics, including against hard-to-drug targets. Absci develops internally owned programs and partners with pharmaceutical and biotech firms, aiming to accelerate biologic drug discovery, improve success rates, and generate milestone and royalty revenues across diverse therapeutic areas.
This description was generated via AI from an annual report.
Updated 8 months ago.